This explainer is more than 90 days old. Some of the information might be out of date or no longer relevant. Browse our homepage for up to date content or request information about a specific topic from our team of scientists.
This article has been translated from its original language. Please reach out if you have any feedback on the translation.
SciLine reaches out to our network of scientific experts and poses commonly asked questions about newsworthy topics. Reporters can use the video clips, audio, and comments below in news stories, with attribution to the scientist who made them.
SciLine reaches out to our network of scientific experts and poses commonly asked questions about newsworthy topics. Reporters can use the video clips, audio, and comments below in news stories, with attribution to the scientist who made them.
Doctors will need to follow FDA and CDC guidance and then discuss with their patients the pros and cons of booster vaccinations dependent on each patient’s overall risk/benefit assessment as to their underlying disease and ongoing therapy with regards to immune suppression. Booster shots will likely be an excellent suggestion for a patient following an organ transplant who is on chronic immune suppression, but it is less clear if booster shots are helpful for a patient with a remote history of cancer without any ongoing therapy that could lead to immune suppression.